UK Industry Welcomes Post-Brexit ‘Windsor Framework’ For Northern Ireland
Executive Summary
UK consumer healthcare industry association, PAGB, has welcomed the landmark “Windsor Framework” agreed by the UK and the EU, which proposes that medicines will take a “green lane” from Great Britain to Northern Ireland, while the UK regulator, MHRA, will have UK-wide responsibility for all drug approvals.
You may also be interested in...
Half Of All OTCs Could Disappear From Northern Ireland Under Current Brexit Rules
UK consumer healthcare association chief Michelle Riddalls tells House of Lords peers that over half of OTC medicines could disappear from Northern Ireland's pharmacy and grocery shelves because of regulatory burdens imposed by the Brexit-related Northern Ireland Protocol.
EU Packaging Regulation Presents Challenge And Opportunity For Consumer Health Industry
A proposed new European Union packaging regulation, which introduces environmental and labelling requirements and extended producer responsibility for medicines, medical devices and food supplements, could be challenging for the region's consumer health industry. But it could also be a spur to creativity, argues Chris Whitehouse, chairman and managing director of Whitehouse Communications.
German Nutraceuticals Market Growth Slows In 2022 But Vitamin C Remains Popular
The growth of sales of nutraceuticals through German pharmacy is slowing post-pandemic, according to IQVIA data. However, there were still double-digit gains for vitamin C and multivitamin products.